Posters
POSTER SESSION 1
EPIDEMIOLOGY – HEALTH ECONOMICS – QUALITY OF LIFE
P1.1 The rate of visual field loss in untreated primary open angle glaucoma in African Carribean
populations
G. Ratnarajan , M. Bindra , J. Kirwan , J. Jay , I. Murdoch (United Kingdom)
P1.2 Use of topical prostaglandin fixed combination in the UK primary care: an observational
study in the Health Improvement Network (THIN) database
J. Loftus, D. Christopoulou , B. Blak, M. Hards (United Kingdom)
P1.3 Diachronic study of glaucoma operations of adults in Greece for the decade 1996-2005
P. Zotta, N. Mylopoulos (Greece)
P1.4 Iris freckles in patients under prostaglandins treatment. A prospective follow-up study
J. Paz Moreno-Arrones, E. Arranz Marquez, M.A. Teus Guezala (Spain)
P1.5 Prevalence of glaucoma in sleep apneA. Prospective study
E. Gutiérrez díaz, M.J. D íaz de Atauri, C. Reinoso Montalvo, R. Alonso Moraleda,
E. Mencía Gutiérrez, M. Castro Liebana, A. Clariana Martín, M.J. Suárez Fernández
(Spain)
P1.6 JAPI study: IOP Screening day in Spain
J.L. Urcelay, V. Polo, L. Fernández-Arias, JAPI Study Group (Spain)
P1.7 Dyslipidaemia as risk factor in primary open angle glaucoma
S. Pavljašević, S. Sefić-Kasumović (Bosnia-Herzegovina)
P1.8 Prevalence of refractive errors in an elderly Koreans
Y.C. Yoo, J.M. Kim, Korean Glaucoma Society (Korea)
P1.9 The effect of an educational session on glaucoma patients knowledge about their disease
and their compliance
P. Leitão, A. Amaral, A.S. Ferreira, J.P. Silva, M. Reina (Portugal)
P1.10 Glaucoma clinic reality : how compliant our glaucoma patients really are and what do we
ophthalmologists do about it?
M. Bozic, P. Hentova-Sencanic, D. Kontic, V. Markovic, L. Marjanovic, S. Avramovic
(Serbia)
P1.11 Pattern of primary open angle glaucoma in a primary Tunisian care center
S. Attia, S. Gargouri, B. Jellti, L. Zone, R. Messaoud, S. Jenzeri, S. Ben Yahia,
M. Khairallah (Tunisia)
P1.12 Systemic and ocular vascular risk factors in normal-tension glaucoma
B. Giambene, F. Galassi (Italy)
P1.13 Normal-tension glaucoma: risk factors and rate of progression
L. Kondrova, M. Fichtl, J. Betková, E. Ružičková (Czech Republic)
P1.14 Normal tension glaucoma and Alzheimers disease: comorbidity?
S.V. Kessing, D.B. Pedersen, U. Mogensen, J.L. Forman, P.K. Andersen, L.V. Kessing
(Denmark)
P1.15 Normotensional glaucoma in Nail-Patella syndrome
A. Carceller, J. Suarez, A. Dou, M. Castany, J. García-Arumí (Spain)
P1.16 Pigment dispersion syndrome diagnosed by floaters
T. Colás Tomás, A. Clariana Martín, A. Fernández Granda, M. Prieto del Cura,
I. Villafruela Güemes, O.K. Rivas Chica (Spain)
P1.17 Local glaucomatous neuropathy risk factors in eyes with pseudoexfoliation syndrome
R. Wasilewicz, J. Kociecki, P. Wasilewicz (Poland)
P1.18 Pseudophakic pseudoexfoliation: is it a clinical risk factor for glaucoma progression?
M.D. Ahn, H.L. Park (Korea)
P1.19 Glaucoma in familial amyloidotic polyneuropathy (ATTR V30M) Portuguese patients
I. Sampaio, P. Borges, M.J. Furtado, M. Beirão, M.J. Menéres, C. Aguiar (Portugal)
P1.20 Risk factors for elevated intraocular pressure in patients with anterior endogenous uveitis
G. Kopayenko, G. Zhaboedov, N. Ivanova, J. Ogbe (Ukraine)
P1.21 Ocular hypertension in isolated extraocular muscle infiltration by leukemia
A. Aydin, U. Aykan, A. Cakir, D. Ersanli (Ankara)
P1.22 Lung adenocarcinoma metastasis affecting the eye. A curious case report of young breast
feeding female
J. Betková, M. Fichtl, L. Kondrova, E. Ružičková (Czech Republic)
P1.23 Secondary glaucoma associated with pseudophakia 4 years after cataract surgery
M. Fichtl, J. Betková, L. Kondrova, E. Ružičková (Czech Republic)
P1.24 Pediatric cataract and secondary glaucoma
P. Tejada Palacios, S. Perucho Martinez, L. Zarratea Herreros, A. Barcelo Mediguchia,
J. De La Cruz Bertolo, E. Gutierrez Diaz (Spain)
P1.25 Secondary glaucoma as associated risk factor for choroid invasive retinoblastoma
A.M. Dorado Lopez-Rosado, L. Zarratea Herreros, Y.W. Eduardo Sanchez, P. Tejada
Palacios, A. Barcelo Mediguchia (Spain)
P1.26 Risk factor for anxiety and depression in patients with glaucoma
F. Mabuchi, K. Kashiwagi, Z. Yamagata, H. Iijima, S. Tsukahara (Japan)
P1.27 Clinic-based observational study of glaucoma patient distribution and drug preference in
Japanese common clinics in 2009
M. Ueno, Y. Ikeda, K. Imai, K. Mori, S. Kinoshita (Japan)
P1.28 Glaucomatous findings in patients with autoimmune rheumatic diseases
V. Shoumnalieva-Ivanova, R. Hristova, R. Shumnalieva, S. Monov (Bulgaria)
P1.29 Retinal arterial macroaneurysm and contralateral amblyopiA. A case presentation
M. Bisca, O. Andrei, A. Furtuna, O. Florescu (Romania)
P1.30 Predictive factors of glaucoma treatment costs in Germany
N. Pfeiffer, C. Wolfram, T. Dietlein, V. Claus, Y. Verboven, K. Lorenz (Germany,
Belgium)
P1.31 Telemedicine screening program for glaucoma using tonometry, scanning laser
opthalmoscopy (HRT) and scanning laser polarimetry (GDX)
M. Muñoz, A. Antón, M. Fallon, M. Sebastian, B. Calderon, A. Morilla (Spain)
P1.32 Strategies for modifying clinical practice in glaucoma diagnosis. Diagnostic logistics
in glaucoma (dialog) educational program
A. Salonikiou, E. Anastasopoulos, P. Founti, E. Panagopoulou, L. Makris, T. Pappas,
V. Kilintzis, C. Economou, F. Topouzis (Greece)
P1.33 Cost minimisation: impact of generics on long term glaucoma management
D. Sood , R. Sood , N. Gupta , R. Sardana , R.K. Bajaj , N.N. Sood (India)
P1.34 Cost-effectiveness analysis of preservative free tafluprost in the treatment of glaucoma and
ocular hypertension
J. Wang, A. Charos, J. Caputo, H. Hu, J. Pellissier (United Kingdom)
P1.35 The assessment of quality of life in glaucoma patients
G. Arikan, O. Celik, U. Gunenc, G. Cingil (Turkey)
P1.36 Visual field loss severity and its impact on quality of life in glaucoma patients determined by
Turkish version of Glaucoma Quality of Life Analysis - 15 Questionnaire
S. Ugurlu, M. Unal, I. Cakir Mermut (Turkey)
P1.37 The role of regular medical check-up in glaucoma progression
O. Vitovska, I. Deryapa, S. Zbitneva, N. Obuhova (Ukraine)
P1.38 The first book for glaucoma patients in Spanish. “Convivir con el glaucoma”
M. Carrasco (Argentina)
P1.39 Patient satisfaction towards trabeculectomy surgery
M. Dey, L. Lawuyi, F. O ‘Sullivan (United Kingdom)
P1.40 Ocular surface and beta-blockers
M. Lester & the Timogel Study Group (Italy)
POSTER SESSION 2
GLAUCOMA PROGRESSION – IMAGING – VISUAL FIELD
P2.1 Distribution of retinal nerve fiber in myopia
J. Park, K. Lee, M. Kim, K.H. Park, S.H. Kang (Korea)
P2.2 A new method for automated CDR measurement in photographic retinal images.
Preliminary results
S. Jimenez, P. Alemany, F. Nuñez, I. Fondon, M. Tirado, C. Serrano, B. Acha (Spain)
P2.3 Longitudinal retinal nerve fiber layer change and visual field change in normal tension
glaucoma
J.H. Lee , S.M. Hyung , K.R. Choi , Y.H. Sohn , K.W. Lee , J. Moon (Korea)
P2.4 Trabeculectomy with or without mitomycin-C using ultrasound biomicroscopy
C. Martínez Belló, R. Alemán Martínez , F. Huste Geronés (Spain)
P2.5 Retinal nerve fiber layer (RNFL) curvature and RNFL thickness in glaucoma and its value
in highly myopic eyes
C.K. Park , H.Y. Park , K.I. Jung , N.Y. Lee (Korea)
P2.6 Relationship between RNFL thickness and global and focal loss volume in the ganglion cell
complex map assessed by spectral domain OCT
C. Lazaro, E. Hernandez, P. Redondo, D. Martinez, J. Perea (Spain)
P2.7 Glaucoma defection capability of Cirrus- OCT and GDx-VCC deviation map
K.R. Sung, J.W. Cho, Y. Lee, M.S. Kook (Korea)
P2.8 Differential inner macular thinning in glaucoma with hemifield visual loss: a Fourier-domain
optical coherence tomography (FD-OCT) study
A. Gupta, N. Anand (United Kingdom)
P2.9 Survey of investigations used for the diagnosis of glaucoma in Poland
M. Misiuk-Hojlo (Poland)
P2.10 Retinal nerve fiber layer thickness in patients with exfoliation, exfoliative glaucoma,
and primary open angle glaucoma
V. Kozobolis, G. Labiris, M. Glynatsis (Greece)
P2.11 Evaluation of OCT-GPA in stable and progressive glaucomatous eyes
E.J. Lee, T. Kim (Korea)
P2.12 Correlation between retinal nerve fiber thickness measurements using high-resolution
optical coherence tomography and standard automated perimetry indices
B. Monsalve, A. Ferreras, J.L. Urcelay, L. Chang, L.E. Pablo (Spain, United Kingdom)
P2.13 GDX Pro with ECC (enhanced corneal compensator) in patients showing anomalous
birefringence pattern artefact (ABP): correlations with perimetric data
E. Martini , M. Guiducci, I. Schenetti (Italy)
P2.14 Spectral domain optical coherence tomography (OCT) findings in megalopapilla
A. Al-Areifi, J. Morales, D.P. Edward (Saudi Arabia)
P2.15 Macular ganglion cell layer asymmetry analysis in preperimetric and early glaucoma
N. Nakano, M. Hangai, S. Mori, M. Nukada, H. Ohashi Ikeda, T. Akagi, A. Nonaka,
N. Yoshimura (Japan)
P2.16 Comparison of glaucoma diagnostic capabilities of cirrus and RTVue OCTs and their
measurement agreement to stratus OCT
J.H. Kim, N.R. Kim, E.S. Lee , S.Y. Kang, G.J. Seong, K.T. Ma, C.Y. Kim (Korea)
P2.17 Relationship between retinal nerve layer thickness and visual field recovery in surgically
treated chiasmal compressive optic neuropathy
C. Ajtony, R. Fustos, Z. Bernad, Z. Biro, E. Mezosi, T. Doczi (Hungary)
P2.18 Correlation of retinal fibre nerve layer thickness and intraocular pressure in patients with
intraocular hypertension and open angle glaucoma
S. Sefic-Kasumovic, L. Ceklic, S. Pavljasevic (Bosnia and Herzegovina)
P2.19 The effect of repeated measurement on the power to detect loss of neuro-retinal rim area
with confocal scanning laser tomography
C. Sandberg Melin, E. Nuija, A. Alm (Sweden)
P2.20 Factors associated with signal strength of retinal nerve fiber layer and macular thickness
measurements obtained by Cirrus optical coherence tomography
K.R. Sung, J.H. Na, Y. Lee, M. Kook (Korea)
P2.21 Comparison of retinal nerve fiber layer thickness between stratus and Spectralis OCT
H.J. Shin, B.J. Cho (Korea)
P2.22 Analyzing nerve fiber layer defect using Fourier domain optical coherence tomography
compared with red-free retinal nerve fiber layer photograph
P. Arintawati, T. Sone, M. Takamatsu, Y. Kiuchi (Japan)
P2.23 Relationship between retinal sensitivity and retinal nerve fiber layer thickness measured
by time domain Stratus OCT™ and spectral domain Cirrus™HD-OCT
J.R. Lee, J. Choi, J.W. Jeoung, J.Y. Choi, K.H. Park, Y. Kim (Korea)
P2.24 Optic disc rotation adjusted structure function relationship using optical coherence
tomography
T. Yamashita, R. Asaoka, D. Garway-Heath (United Kingdom, Japan, Italy)
P2.25 Comparison between Stratus OCT and HRT III in evaluating optic nerve head measures
L. Micelli Ferrari, V. Pace, T. Micelli Ferrari, M. Lorusso (Italy)
P2.26 Prediction of glaucomatous change in ocular hypertension with optical coherence
tomography
S. Popovic Suic, M. Ekert (Croatia)
P2.27 Comparison of Heidelberg spectralis OCT and GDx VCC scanning laser polarimeter in the
detection of glaucoma
P. Haidova, P. Masek, L. Kolarcik (Czech Republic)
P2.29 Comparison of spectral domain OCT, and scanning laser ophthalmoscopy findings
in normal eyes with a high cup to disc ratio
B. Koucheki, H. Hashemi (Iran)
P2.30 Correlation of ganglion cell complex thickness with frequency doubling technology
perimetry in open-angle glaucoma with hemifield abnormalities
S. Konno, A. Tomidokoro, M. Aihara, M. Araie (Japan)
P2.31 Structural and functional assessment for glaucomatous eyes with diffuse retinal nerve fiber
layer atrophy: diffuse atrophy imaging study report 3
J.W. Jeoung, S.H. Kim, K.H. Park, T. Kim, D.M. Kim (Korea)
P2.32 Reproducibility of peripapillary retinal nerve fiber layer thickness measured with spectral
domain optical coherence tomography in glaucomatous eyes
P. Calvo, A. Ferreras, L. Gil-arribas, L. Pablo (Spain)
P2.33 Correlation of cup/disc ratio (C/D) and retinal nerve fibre layer thickness (RNFL) in patients
with intraocular hypertension and open angle glaucoma
L. Ceklic, S. Sefic-Kasumovic, S. Pavljasevic (Bosnia and Herzegovina)
P2.34 Structurally functional changes retinal pigment epithelium at a primary glaucoma
V. Strahov, V. Alekseev, A. Yartsev (Russia)
P2.35 Correlation between frequency doubling technology and optical coherence tomography in
ocular hypertension people
C.C. Gonzalez , J. Paz Moreno-arrones, I. Dapena Sevilla, M.A. Castejon Cervero,
M.A. Teus Guezala (Spain)
P2.36 Comparison of optic disc topography between non-glaucomatous cases with rheumatoid
arthritis and normal subjects
F. Ozturk, U.Elgin, E. Sen, E.aksoy, D. Dulgeroglu, O. Aksoy (Turkey)
P2.37 Reliability of HRT III Moorfields regression analyses (MRA) and Glaucoma Probability Score
(GPS) in glaucoma suspects. Relation with optic disk size
L.M. Voinea, A.M. Dascalu, C. Alexandrescu, A. Panca, M. Chioaru, M. Ghita,
R. Ciuluvica, E. Ungureanu, A. Sescioreanu, R. Ilinca (Romania)
P2.38 Diagnostic accuracy of peripapillary retinal nerve fibre measurement with spectral domain
OCT and short-wavelength perimetry in preperimetric glaucoma
A. Sket Kontestabile, B. Cvenkel (Slovenia)
P2.39 Role of GDX in identifying false positive glaucoma referrals
R. Job, S. Walker, B. Moriarty (United Kingdom)
P2.40 Comparison of the morphological characteristics of the glaucomatous optic nerve damage,
in different types of open angle glaucoma
M.A. Castejon, G. Bolivar, E. Arranz-Marquez, J. Arevalo-Serrano, M. Teus (Spain)
P2.41 Optical coherence tomography in glaucomatous and myopic eyes
M. Atanassov, M. Konareva-Kostianeva, A. Gerdzhikov (Bulgaria)
P2.42 Comparison of retinal nerve fibre layer thickness measured with a time-domain (stratus
OCT) and a spectral-domain (Cirrus HD OCT) optical coherence tomography
F. Trancoso Vaz, C. Marques neves, A. Gonçalves, D. Cavalheiro, A. Santos, F. Silva,
P. Santos Kaku, F.E. Esperancinha (Portugal)
P2.43 Correlation between structural and functional damage in three different types of open angle
glaucoma
M. Teus, M.A. Castejon , G. Bolivar , E. Arranz-Marquez , J. Arevalo-Serrano (Spain)
P2.44 Retinal nerve fibre layer measurements in obstructive sleep apnea-hypopnea syndrome
Mª.J. Muniesa, F. Barbe, M. Sanchez, C. Jurjo, C. Sanchez, M. Lumbierres, R. Espinet,
A. Traveset, V. Huerva (Spain)
P2.45 Evaluation of scanning laser polarimetry (GDxVCC) findings in individuals with exfoliation
syndrome compared with normal controls
A.T. Dimopoulos, D. Mikropoulos, K. Kaltsos, T. Embeslidis, G. Moumtzis,
A. Papanastasiou, V. Toumanidou, B.A. Haidich, G. Hollo, A.G.P. Konstas
(Greece, Hungary)
P2.46 Comparison of Humphrey visual field, Heidelberg retina tomograph 3 and Stratus optical
coherence tomography in patients with primary open angle glaucoma, normal tension
glaucoma and ocular hypertension
U. Gunenc, Z. Ayhan, G. Arikan, G. Cingil (Turkey)
P2.47 Will healthy retina factors rise specificity of glaucomatous neuropathy detection with OCT
use?
R. Wasilewicz, J. Kociecki, P. Wasilewicz (Poland)
P2.48 Comparison between TNT 2, event based GPA and trend VFI analysis software in a
glaucoma population
M.P. Casas de Llera, M. Gonzalez de la Rosa, L. Jaumandreu, G. Rebolleda,
F.J. Muñoz negrete, M. Pérez López (Spain)
P2.49 Regional rates of progression in glaucoma and discrimination of fast and slow components
E. Bitrian, D. Mock, A. Coleman, A. Afifi, F. Yu, K. Nouri-Madhavi, J. Caprioli (USA)
P2.50 Effect of presbyopic correction on visual field in pseudophakic eye with multifocal
intraocular lens
N. Kitnarong, P. Jampathong, I. Treesit (Thailand)
P2.51 Noise-corrected pointwise progression analysis of automated visual fields
D.W. Richards, S. Roland (USA)
P2.52 Investigating the diagnostic performance of the newly-developed “Structure-Function Visual
Field” test grid
R. Asaoka, R. Russell, D. Garway-Heath (United Kingdom, Italy)
P2.53 Peripapillary microperimetry in ocular hypertension
M. Savastano, L. Baraggia, V. Belloli (Italy)
P2.54 Relationship between rarebit perimetry and Heidelberg retinal tomography III parameters
A. Akman, B. Aynaci Kahraman, Y. Aydin akova (Turkey)
P2.55 The significance of SWAP and SAP in revealing glaucoma changes in patients with migraine
Y.S. Astakhov, D.M. Nefedova, E.L. Akopov (Russia)
P2.56 Patterns of glaucomatous visual field defects and 5-20 years progression in a cohort of 532
eyes
S.A. Gandolfi, D. Paoli, P. Brusini, C.E. Traverso (Italy)
P2.57 Comparison of visual field defects between juvenile-onset primary open-angle glaucoma
and juvenile-onset normal tension glaucoma
C. Yoo, J. Park, Y.Y. Kim, J.Y. Lee (Korea)
P2.58 Pulsar perimetry reproducibility in normal subjects
A.M. Fernandez-Vidal, A. Ruiz-Calvo, C.D. Mendez-Hernandez,
J.M. Martinez-De-La-Casa, F. Saenz-Frances, S. Perez-Trigo, O. Rayward,
C. Martin-Valdizan, J. Garcia-Feijoo (Spain)
P2.59 Study of effect of change in learning octopus perimetry (TOP) to Humphrey (SITA FAST)
J. Guzman Blazquez, F. Sellers Lopez, V. Martinez Sanchez, D. Dacosta Ballesteros,
T. Perez Martinez, P. Ortega Campos (Spain)
P2.60 Characteristics of Humphrey perimetry in patients with senile cataract
N. Voronova, N. Ivanova (Ukraine)
P2.61 Assessment of the peripheral visual field with semi-automated kinetic perimetry in patients
with end-stage glaucoma
K. Nowomiejska, T. Zarnowski (Poland)
P2.62 Effect of cataract extraction on Octopus perimetry in patients with glaucoma
J. Fraile-Maya, C.D. Méndez-Hernández, F. Sáenz-Francés San Baldomero,
A. Fernández-Vidal, J. García-Feijoo, J.M. Martínez-De-La-Casa, J. García-Sánchez
(Spain)
P2.63 A new method to address the issue of validating methods to assess glaucomatous visual
field progression
P.J.G. Ernest, C.A.B. Webers, H.J.M. Beckers, J.S.A.G. Schouten (The Netherlands)
P2.64 Visual field asymmetry in new diagnosed primary open angle glaucoma
V. Andreic, A. Miljkovic, N. Babic (Serbia)
P2.65 The effect of topical cyclosporine A treatment on perimetry results of the patients with
glaucoma and severe trachomatous dry eye
M. Guzey, A. Satici (Turkey)
P2.66 Correlation between basal IOP and functional damage in three different types of open angle
glaucoma (OAG)
E. Arranz-Marquez , M.A. Castejon , G. Bolivar , J. Arevalo-Serrano, M. Teus (Spain)
P2.67 Effectiveness of administration of travoprost/tymolol fixed combination in patients with open-
angle glaucoma for 2 years
N.V. Ivanova, I.I. Dergalo, G.I. Kondratiuk, M.I. Ivanova (Ukraine)
P2.68 Assessment of anterior chamber changes with Visante OCT after prophylactic peripheral
Nd-YAG Laser iridotomy in primary closed angle patients
B. Satana, G. Varan, C. Altan, B. Demirel, A. Demirok, O.F. Yilmaz (Turkey)
P2.69 The effect of brimonidine and timolol fixed combination therapy on anterior ocular segment
configuration
J.M. Kim, C.Y. Kim, T. Kim, H.K. Kim, K.H. Park (Korea)
P2.70 The correlation of angle opening distance, angle recess area and trabecular-iris angle in the
quantitative evaluation of the anterior chamber angle by ultrasound biomicroscopy
I. Salcan , U. Aykan, K. Çolakoglu, A. Aydin, D. Ersanli (Turkey)
P2.71 Analysis of light-dark changes in iris convexity in eyes with occludable angles
F. Hirose, M. Hata, S. Ito, Hiroki Kimakura, Y. Hirami, Y. Kurimoto (Japan)
P2.73 Anterior segment optical coherence tomography imaging of acute primary angle closure
eyes at presentation and after argon laser peripheral iridoplasty or conventional systemic
medical therapy
C. Sng, M.C. Aquino, E. Chan, S.C. Loon, S.M. Yeong, J. Aduan, P. Chew (Singapore)
P2.74 Scheimpflug system image analysis (Pentacam®) for monitoring angle closure glaucoma
secondary to shallow anterior chamber and plateau iris
F.J. Guijarro Oria, P. Gomez Perez, I.T. Gordo Molina, M. Montero Rodriguez,
M.D. Lago Llinas, E. Gutierrez díaz (Spain)
P2.75 An in vivo confocal microscopy analysis of effects of topical beta-blockers antiglaucoma
therapy without preservative (timololo 0.1% in gel) on conjuctiva morphology
P. Frezzotti, G. Haka, I. Motolese, S. Peruzzi, C. Batisti, E. Motolese (Italy)
P2.76 Angle configuration changes after phacoemulsification measured with anterior segment
optical coherence tomography (AS OCT)
A. Bron, M.L. Bidot, S. Bidot, A. Muselier, C. Creuzot-Garcher (France)
P2.77 Morphometric characteristics of the cornea in patients with chronic simple glaucoma and
healthy subjects
F. Saenz-Frances, A. Fernandez Vidal, L. Borrego, E. Santos Bueso, C. Mendez Hernandez,
J.M. Martinez de La Casa, J. Garcia Sanchez, J. Garcia Feijoo (Spain)
P2.78 Visual field loss in normal and high tension glaucoma with same optic nerve head
morphologic characteristics
J. Häntzschel, F. Sorgenfrei, L.E. Pillunat (Germany)
P2.79 Are OCT or SLT always useful in the diagnosis of glaucoma suspects? A case report
A. Popa Cherecheanu, R. Pascu, M. Ghita (Romania)
P2.80 Iridocorneoendotelial syndrome: diagnostic scheme for unilateral ocular hypertension
M. Moussalli, J. Bekerman (Argentina)
P2.81 Chandler syndrome: a diagnostic challenge
D. Dacosta Ballesteros, J. Guzman Blazquez, C. Lazaro Garcia, J. Garcia Feijoo,
C. Pizzamiglio Martin, C. Fernandez Gonzalez (Spain)
P2.82 Glaucoma Diagnostic Performance of Macular and Retinal nerve fiber layer by
Spectral-domain Optical Coherence Tomography
R.S. Kyung, H.N. Jung, L. Youngrok (Korea)
P2.83 Performance of the visual field index slope for assessing glaucomatous progression
Y. Itoh, T. Nakano, T. Noro, S. Ogawa, H. Matsuda, M. Tatemichi, H. Tsuneoka (Japan)
P2.84 The measure of color vision in early primary open angle glaucoma
K. Koev, R. Georgiev (Bulgaria)
P2.85 Correlation between glaucoma probability score and spectral-domain optical coherence
tomography in healthy and glaucomatous eyes
L. Gil-arribas, A. Ferreras, P. Calvo, P. Luis (Spain)
P2.86 Relationship between visual field global indices and retinal nerve fiber layer thickness as
measured by scanning laser polarimetry with variable and enhance corneal compensation
and Optical coherence tomography
Javier Benitez del Castillo, A. Martinez, T. Ragi (Spain)
P2.87 Early complications with the Ahmed glaucoma valve for childhood glaucoma associated
with Sturge-Weber syndrome
J. Zarallo Gallardo, M.B. Pastor nieto, J. Peralta Calvo, J. Abelairas Gómez (Spain)
P2.88 Ultrasound biomicroscopy in evaluation of supracilicary space in patients with
pseudoexfoliative glaucoma
T. Botabekova, N. Aldasheva, E. Chuikeyeva, A. Bulgakova, K. Kenjebaeva
(Kazakhstan)
P2.89 Determination of anterior chamber parameters in subjects with pseudoexfoliation syndrome
using rotating Scheimpflug camera
M.A. Costa, M. Macedo, M.J. Menéres, C. Aguiar (Portugal)
P2.90 Inter-examiner reproducibility of ocular response analyzer using the Waveform Score
A. Mandalos, L. Makris, N. Dervenis, V. Kilintzis, F. Topouzis (Greece)
P2.91 Clinical evaluation of a servo controlled applanation resonance tonometer
G. Jóhannesson, P. Hallberg, A. Eklund, C. Lindén (Sweden)
P2.92 Intraocular pressure changes during flight
M. Ayala, I. Landau Högbeck, E. Chen (Sweden)
P2.93 Changes in corneal hysteresis after IOP reduction surgically or medically to patients with
open angle glaucoma
G. Kopsinis, A. Charonis, A. Charonis, A. Manaios, E. Avramidou, T. Filippopoulos
(Greece)
P2.94 Comparison of the corneal biomechanical properties with the Reichert ocular response
analyzer (ORA) in African and Caucasian glaucoma patients
F. Hautenauven, J. Jamart, M. Detry-Morel (Belgium)
P2.95 Evaluation of SENSIMED Triggerfish® 24-Hour monitoring in healthy subjects and
glaucoma patients
K. Lorenz, N. Rauch, C. Kramann, M.M. Keilani, N. Pfeiffer (German)
P2.96 Long-term effect of latanoprost on central corneal thickness in normal tension glaucoma
H.J. Kim, B.J. Cho (Korea)
P2.97 Central corneal thickness in patients with exfoliation syndrome, exfoliative glaucoma,
primary open-angle glaucoma and ocular hypertension
D.G. Mikropoulos, A.I. Economou, K. Kaltsos, K. Boboridis, A.T. Dimopoulos,
I. Georgiadou, M.B. Nasr, N. Ziakas, A.G.P. Konstas (Greece)
P2.98 A new tono/pachymeter TonopachY. Clinical comparison of tonometric measurement with
Goldmann tonometry and pachymetric measurement with Pentacam and ultrasound
pachymetry
Y.J. Lee, E.S. Lee, C.Y. Kim, S.M. Hong, G.J. Seong, J.H. Kim, N.R. Kim, K.T. Ma
(Korea)
P2.99 Do the prostaglandin analogues reduce central cornea thickness?
M. Iester, P. Brusini, P. Frezzotti, G. Manni, D. Paoli, M. Rolando, T. Rolle, M. Uva,
R. Altafini, E. Martini, G. Milano, A. Perdicchi, G. Rossi, F. Scrimieri, M. Vetrugno,
L. Rossetti, A. Rossi, S. Telani (Italy)
P2.100 Central corneal thickness in a healthy Spanish population
J. Gros-Otero, C. Arruabarrena , M. Teus (Spain)
P2.101 The comparison of intra ocular pressure (IOP) values measured by GOLDMANN
applanation tonometer (GAT) and Pascal dynamic contour tonometer (PDCT)
in keratoconus patients
Z. Tuncer, S. Erdem (Turkey)
P2.102 Comparison of intraocular pressure (IOP) changes after intravitreal triamcinolone
acetonide versus bevacizumab injection
S. Park, D. Park, S. Ha (Korea)
P2.103 Comparison of dynamic contour tonometry, ocular response analyzer tonometry and
Goldmann applanation tonometry in glaucoma patients
P. Alcocer, A. Lanzagorta (Spain)
P2.104 Rebound, non-contact and Goldmann applanation tonometer: comparison of intraocular
pressure and influence of central corneal thickness
S. Hong, J.R. Lee, J. Choi, J.Y. Choi, Y. Kim (Korea)
P2.105 Agreement between central corneal thickness measured by ultrasound pachymetry and
minimal and central thicknesses determined using the Pentacam
L. Borrego, F. Saénz-Frances, A.F. Vidal, C. Méndez Hernández, J.M. Martínez de La
Casa, E. Santos Bueso, J. García Sánchez, J. García Feijóo (Spain)
P2.106 The importance of diagnostics and therapy of 24 hour continuous IOP monitoring in
normotension glaucoma: a case report
B. Pajic, B. Pajic-Eggspuehler, I. Haefliger (Switzerland)
P2.107 Comparison of different tonometric measurement methods at high intraocular pressure
values in glaucoma cases
M.E. Turacli, S. Ozturk, A. Sengun, E. Tanriverdi (Turkey)
P2.108 Comparison of optic disc topography between Graves’ diseases and normal subjects
E. Sen, D. Berker, U. Elgin, Y. Tutuncu, H. Ozal, S. Guler, F. Ozturk (Turkey)
P2.109 Effect of intravitreous ranibizumab on the retinal nerve fiber layer thickness. Preliminary
results
A. Ruiz-Calvo, J.M. Martinez-de-la-Casa, J. Reche-Frutos, C. Calvo-Gonzalez,
J. Donate-Lopez, F. Saenz-Frances, A. Valverde-Megias, J. Garcia-Feijoo (Spain)
P2.110 Agreement between optic nerve head examination using the R rule and visual field
analysis
A.A. Dahawy, N.J. Nagelkerke (United Arab Emirates)
POSTER SESSION 3
MEDICAL & SURGICAL TREATMENT
P3.1 Comparison of once-daily morning or evening dosing of PF-03187207, a novel nitric
oxide donating prostaglandin f2-alpha analogue, vs. latanoprost in hypertensive eyes
S. Raber, M. Zhang, R. Courtney, D. Eveleth (USA)
P3.2 Travoprost BAK-free formulation preserved with polyquaternium-1 is an effective option for
achieving IOP reduction while eliminating BAK exposure in glaucoma patients
P. Denis, S. Gandolfi, I. Stalmans, L. Volksone, G. Laganovska (France, Italy, Belgium,
Latvia)
P3.3 Interest of prophylactic hypotensive drugs in ocular hypertension (OHT) after intravitreal
injection: about 150 injections
H. El Chehab, A.Le Corre, G. Ract-Madoux, N. Salaun, B. Swalduz, G. Mourgues,
C. Dot (France)
P3.4 Glaucoma management system 3©: a glaucoma dedicated electronic chart recorD.
Long-term use in a clinical based setting
D. Paoli (Italy)
P3.5 A multicenter, double-masked, randomized, dose-ranging study of latanoprost efficacy and
safety in primary open-angle glaucoma (POAG) and ocular hypertension (OH)
C. Tressler, C. Starita, D. Eveleth (USA, United Kingdom)
P3.6 Effect of a new electronic reminder system on adherence with topical ocular therapy
M. Hermann, L. Ersoy, M. Diestelhorst (Germany)
P3.7 Comparison of conjunctival impression cytology in primary open-angle glaucoma, ocular
hypertension and normal subjects
U. Elgin, F. Ozturk, M. Citirik, H. Haksever, K. Serdar, E. Sen, H. Ustun, H. Ozal
(Turkey)
P3.8 Safety of a 3-month treatment with long acting carteolol 2% versus long acting timolol
0.50% in glaucoma patients. A randomized, investigator-masked, multicentre study
F. Chiambaretta, T. Zeyen, E. Ruzickova, I. Liehneova, J.P. Silva, M. Misiuk-Hojlo,
L. Marie Coulangeon, C. Allaire (France, Belgium, Czech Republic, Portugal, France)
P3.9 Effects of intracameral triamcinolone acetonide, dexamethasone and placebo on short-term
intraocular pressure following uneventful phacoemulsification
A. Akman, I. Kilic, A. Karalezli, M. Borazan, Y. Aydin akova (Turkey)
P3.10 Effect of central corneal thickness in intraocular absorption of Travoprost 0.004%
O. Rayward, J.M. Martínez de la Casa, L.B. Sanz , C.D. Méndez, A.F. Vidal,
F. Saez Francés, C. Martín Valdizán, J. García Feijoo (Spain)
P3.11 Influence of baseline treatment on the efficacy of prostaglandin analogues fixed combinations
M. Centofanti, F. Oddone, M. Vetrugno , G. Manni, P. Fogagnolo, L. Tanga, P. Ferreri,
L. Rossetti (Italy)
P3.12 Keratoepitheliopathy related with anti-glaucomatous eye drops
M.A. Costa, M. Macedo, M.J. Menéres, C. Aguiar, I. Sampaio, P. Reimao (Portugal)
P3.13 Adherence with the fixed travoprost/timolol combination therapY. A multi-centre study in
ambulant glaucoma patients
M. Diestelhorst, The Travalert® Study Group (Germany)
P3.14 Dorzolamide eye drops can improve foveoschisis induced by X-linked retinoschisis
H.G. Kang, K.W. Lee, S.M. Hyung, J.H. Lee, S.C. Cha (Korea)
P.3.15 Comparison of the hypotensive actions of fixed combinations of timolol-brimonidine and
timolol-dorzolamide
F. Saenz-Frances, J.M. Martinez de La Casa, C. Mendez Hernandez,
A. Fernandez Vidal, E. Santos Bueso, A. Ruiz Calvo, L. Borrego, M.A. Valles Romero,
J. Garcia Sanchez, J. Garcia Feijoo (Spain)
P3.16 Treatment of patients with ocular hypertension and glaucoma with preservative free
tafluprost 0.0015%: results of a multi-center open-label observational study
C. Erb, I. Lanzl, S. Seidova, F. Kimmich (Germany)
P.3.17 Pseudophakic refraction as a possible way to control post-phaco IOP decline
A. Zolotaryov, E. Karlova, I. Stebneva, O. Pavlova (Russia)
P3.18 Levomoprolol, a beta-blocker of third generatioN. Marked ocular hypotensive effect without
bradicardia and bronchospasm in asthmatic patients
G. Garofalo, J. Pecori Giraldi, G. Stecchi, M. Virno (Italy)
P3.19 Bimatoprost and bimatoprost / timolol fixed combination in glaucoma and ocular hypertension
A. Katsanos, A. Dastiridou, M. Fanariotis, M. Kotoula, E. Tsironi (Greece)
P3.20 A prospective, observational study of the long-term impact of latanoprost/timolol fixed
combination (LTFC) in glaucoma and ocular hypertension patients
O. Schwenn, B. Heckmann, C. Guzy, P. Miller (Germany, United Kingdom)
P3.21 Comparison of the clinical efficacy and tolerability of latanoprost 0.005% eye drops test for
mulation, for the treatment of ocular hypertension (OH) and primary open angle glaucoma
(POAG), with Xalatan® 0.005% eye drops
A. Dietrich, H. Allmeier, I. Grundmane, G. Mazur-Piotrowska, A. Mitkova, P. Neshev,
S. Shahanova-Markova, C. Allaire (Latvia, Poland, Bulgaria)
P3.22 Intraocular pressure, topical therapy and visual field in pregnancy
C. Mendez Hernandez, J. Garcia Feijoo, A. Fernandez Vidal,
F. Saenz Frances San Baldomero, J.M. Martinez de La Casa Fernandez Borrella,
C. Martin Valdizan, E. Santos Bueso, J. Garcia Sanchez (Spain)
P3.23 Evaluation of the action of stellate ganglion block and retrobulbar block in painful glaucoma
patients
C.R. Lauretti, G.R. Lauretti, A. Lauretti-Filho, M.D.L. Veronese Rodrigues (Brazil)
P3.24 Efficacy of latanoprost on circadian mean and short-term fluctuation assessed with a new
diurnal intraocular pressure curve method
R. Borrone (Argentine)
P3.25 Application of intracameral bevacizumab (Avastin) in patients with proliferative diabetic
retinopathy and neovascular glaucoma
K. Koev (Bulgaria)
P3.26 Glaucoma: is it a complex regional pain syndrome (CRPS) type II?
C.R. Lauretti, G.R. Lauretti, A. Lauretti-Filho (Brazil)
P3.27 Non interventional study in Slovak patients with primary open angle glaucoma and/or
ocular hypertension treated with xalacom after failure of previous antiglaucoma
therapy due to ineffectivity or intolerance
E. Vodrazkova, N. Majtanova (Slovak Republic)
P3.28 Travoprost BAK-free is less cytotoxic on cultured human conjunctival epithelial cells than
latanoprost or travoprost formulations preserved with BAK
F. Brignole-Baudouin, L. Riancho, H. Liang, C. Baudouin (France)
P3.29 Evaluation of in vivo ocular surface toxicity associated with travoprost BAK-free versus
BAK-preserved travoprost and latanoprost ophthalmic solutions
H. Liang, F. Brignole-Baudouin, L. Riancho, C. Baudouin (France)
P3.30 Ocular surface safety of a new antiglaucoma BAK-free fixed combination of travoprost
0.004%/timolol 0.5% versus BAK-preserved travoprost 0.004%/timolol 0.5% and
latanoprost 0.005%/timolol 0.5% ophthalmic solutions: an in vivo toxicity study
A. Pauly, H. Liang, L. Riancho, C. Baudouin, F. Brignole-Baudouin (France)
P3.31 Impression cytology of the conjunctival epithelium after antiglaucomatous treatment with
latanoprost and travoprost
M. Garcia-Catalan, L. Morales-Fernández, A. Muñoz-Hernández,
J. Benitez-del-Castillo, C. Mendez-Hernandez, F. Saenz-Frances, J. Garcia-Feijoo
(Spain)
P3.32 A comparative toxicological study between benzalkonium- and polyquad-containing anti
glaucoma fixed combinations of travoprost 0.004%/timolol 0.5% on conjunctival epithelial
cells using microtitration fluorimetric assays on live cells
Z. Nakib, H. Liang, C. Baudouin, F. Brignole-Baudouin (France)
P3.33 Medical induced pigmentary affection trabecular meshwork of long-term exposure to topical
intraocular pressure lowering medicines (preliminary report)
V. Ogorodnikova, V. Gorodnichy, E. Tsalkina, M. Makanin, A. Kuroyedov (Russia)
P3.34 Long-term outcomes of selective laser trabeculoplasty in open-angle glaucoma and ocular
hypertension
P. Frezzotti, I. Motolese, S. Peruzzi, P. Mittica, S. Bagaglia, E. Motolese (Italy)
P3.35 Long-term clinical outcomes of trabeculotomy ab externo for the treatment of glaucoma after
corneal transplantation
K. Mori, Y. Ikeda, M.o ueno, K. Imai, S. Kinoshita (Japan)
P3.36 Efficacy and results of the selective laser trabeculoplasty (SLT) for the open angle glaucoma
(OAG) over a 6 & 1/2-year period
A. Porta, F. Ferentini, F. Romanazzi (Italy)
P3.38 Laser iridoplasty for plateau iris syndrome
E. Bluwol, Y. Lachkar, H. Cohn (France)
P3.39 Pascal laser trabeculoplasty for open angle glaucoma
B. Mohammed, D. Nguyen, S. Banarjee, J. Diamond (United Kingdom)
P3.40 Effect of selective lasertrabeculoplasty (SLT) on ocular hemodynamics in glaucoma
K. Hornykewycz, E. Spörl, R. Stodtmeister, L.E. Pillunat (Germany)
P3.41 The effect of selective laser trabeculoplasty regarding to central corneal thickness
I. Yalvac, U.A. Dinc (Turkey)
P3.42 The efficacy of the selective laser trabeculoplasty as an adjunctive treatment for glaucoma
and the influential factor on the success of the selective laser trabeculoplasty
Y. Sohn, H. Park, H. Ki, S. Jin (Korea)
P3.43 Glaucoma and ophthalmohypertensia treatment with diode laser trabeculoplasty in Armenia
I. Buniatyan, L. Voskanyan (Armenia)
P3.44 Comparison of the outcomes of trabectome to viscocanalostomy for primary open-angle
glaucoma
M. Maeda, M. Watanabe, K. Ichikawa (Japan)
P3.45 Clinical results of selective laser trabeculoplasty in the treatment of primary open angle
glaucoma versus pseudoexfoliative glaucoma
A. Muñoz-Hernandez, C. Mendez-Hernandez, M. Garcia-Catalan, J. Garcia-Feijoo,
F.o Saenz-Frances, J. Martinez-de-la-Casa, A. Fernandez-Vidal, J. Garcia-Sanchez
(Spain)
P3.46 Revival of failed filtration blebs with angled MVR blade
R. Mathew, Y. Chong, C. Migdal (United Kingdom)
P3.47 Concept of a pressure-controlled microstent for glaucoma therapy
R.A. Allemann, W. Schmidt, C. Schultze, O. Stachs, M. Loebler, K. Sternberg,
B. Chichkov, A. Wree, K.P. Schmitz, R.F. Guthoff (Germany)
P3.48 YAG laser iridotomy treatment for angle closure glaucoma
B. Wieczorek (Poland)
P3.49 Selective laser trabeculoplasty efficacy and the effect of prostaglandin analogs on success
of intraocular pressure reduction
A. Wegner, J. Huber, R. Khoramnia, A. Erben (Germany)
P3.50 Influence of trabeculectomy on diurnal and nocturnal intraocular pressure fluctuations
S. Leippi, F. Grehn, T. Klink (Germany)
P3.51 Quantitative assessment of changes in trabeculectomy blebs after laser suture lysis using
anterior segment coherence tomography
C. Sng, M. Singh, P. Chew, C. Ngo, C. Zheng, T. Tun, J. See, S.C. Loon, T. Aung
(Singapore)
P3.52 A novel filtration procedure performed by CO2 Laser and OT-134 systems. Results of multi
national clinical studies
N.Geffen, Y. Ton, E. Dahan, E. Asia (Israel)
P3.53 Biologic fibrin sealant use in the conjunctival closure in trabeculectomy
O. Rayward, J.M. Martínez de la Casa A. Ruiz Calvo, C.D. Méndez, A. Fernández Vidal,
F. Saez Francés, C. Martín Valdizán, J. García Feijoo (Spain)
P3.54 Safety of topical anti-VEGF (Ranibizumab) after filtration surgery for glaucoma
F. Bochmann, C. Becht, M. Thiel (Switzerland)
P3.55 Safety in trabeculectomy with double low dose of mitomycin C
D. Errico, F. Scrimieri, G. Iarossi, R. Riccardi, R. Fedeli (Italy)
P3.56 Combined viscocanalostomy-trabeculectomy (VISCO-TRAB) for management of advanced
glaucomA. A prospective comparative study
T. Eid, W. Tantawy (Saudi Arabia)
P3.57 Trabeculectomy with deep scleral tunnel, a modification of the technique
M. Eldeeb (United Arab Emirates)
P3.58 SLT retreatment
S. Kim, E. Choi, J. Park (Korea)
P3.59 SclerotrabeculectomY. A new approach for glaucoma surgery
V. Kozobolis, E. Kaloghianni (Greece)
P3.60 Clinical evaluation of “double scleral flap” fornix. Based trabeculectomy with mitomycin C
M. Zoric Geber, Z. Mandic, K. Novak Laus (Croatia)
P3.61 Comparison between phacotrabeculectomy combined with and without biodegradable
matrix implant for treatment of open angle glaucoma
R. Altafini, R. Melis, A. De Gregorio, S. Morselli (Italy)
P3.62 An adhesive ocular bandage for the conjunctiva-limbal wound in limbal-based
trabeculectomy
D. Calladine, G. Ratnarajan, J. Mcallister (United Kingdom)
P3.63 Outcome of repeat trabeculectomies
C. Olali, A. Rotchford, A. King (United Kingdom)
P3.64 Two-year follow-up of routine usage of 5-fluor-uracil to “enhance” trabeculectomy
I. Kumar, L. Clearkin (United Kingdom)
P3.65 The relationship between early and late intraocular pressure measurement following
primary trabeculectomy with antifibrotic agents
K. Arashvand, B. James (United Kingdom)
P3.66 Cystic bleb formation and related complications following trabeculectomy
V. Dimovska (Republic of Macedonia)
P3.67 Trabeculectomy with absorbable suture of the scleral flap and subconjunctival
biodegradable collagen matrix implant (OlogenTM) in refractory glaucoma
B. Tzvetkova, B. Anguelov (Bulgaria)
P3.68 Augmented penetrating deep sclerectomy (APDS). A safe technique with excellent results
V. Kayarkar (United Kingdom)
P3.69 Short-term results of nasal-superior trabeculectomy
N. Shoji, T. Morita, K. Iijima, K. Shimizu (Japan)
P3.70 Incidence and management of cystic blebs following fornix-based trabeculectomy with
mitomycin-C
I. Kocak-Midillioglu, M. Arikan, F. Yulek, S. Simsek (Turkey)
P3.71 235 consecutive trabeculectomies. Techniques, results and complications
N. Mylopoulos, P. Zotta (Greece)
P3.72 Challenges in glaucoma management. A case report
L. Mary Voinea, C. Alexandrescu, A.M. Dascalu, A. Panca, R. Ciuluvica, R. Pascu,
C. Mitulescu, R. Simionescu, A. Vrapciu (Romania)
P3.73 Pigmentary glaucoma iris configuration and its response to laser iridotomy studied with
anterior segment OCT
P. Alcocer, A. Lanzagorta (Spain)
P3.74 Nd:YAG iridotomy in pigmentary glaucoma
J. Suarez Jauregui, L. Velez Escola, A. Carceller Guillamet, A. Dou Saez de Vizmanos,
M. Castany aregall (Spain)
P3.75 The outcome of combined laser iridotomy and selective laser trabeculoplasty in a case with
bilateral ocular hypertension secondary to pigment dispersion caused by extensive
irido-ciliary cysts
U. Aykan, M. Sabahyildizi, I. Salcan, A. Aydin, D. Ersanli (Turkey)
P3.76 Trabeculectomy and non-penetrating deep sclerectomy in pseudoexfoliative glaucoma with
or without cataract surgery
P. Gómez, E. Gutiérrez, M.J. Suárez, M. Montero, M.D. Lago , E. Mencía (Spain)
P3.77 Antiproliferative effect of nimodipine in human conjunctival fibroblasts in vitro
F.J. Gonzalvo Ibáñez, M.I. Fuertes Fernádez, L. Izaguirre Roncal (Spain)
P3.78 Nimodipine inhibits human conjunctival fibroblastic migration and attachment in vitro
F.J. Gonzalvo Ibáñez , M.I. Fuertes Fernádez , L. Izaguirre Roncal (Spain)
P3.79 Surgical outcome of mitomycin C soaked collagen matrix implant in trabeculectomy
Y. Jin Ho, K. Chul Min, K. Changwon (Korea)
P3.80 Avastin™ intrablebal injection in the cases with failed trabeculectomy in pseudophakic eyes
L. Voskanyan (Armenia)
P3.81 To investigate histologically the effect of local TNF alpha inhibition on conjunctiva and tenon
fibroblastic activity during wound healing period
D. Ucar, O. Ocakoglu, S. Solakoglu (Turkey)
P3.82 Amniotic membrane using as an trabeculectomy adjuvant in glaucoma patients with
different risk of surgery failure
G. Vashkevich, T. Imshenetskaya, H. Sitnik (Belarus)
P3.83 Changes in gene expression after non-penetrating deep sclerectomy
I. Rodriguez-agirretxe, I. Garcia, A. Acera, N. Gonzalez, T. Suarez, A. Urkola (Spain)
P3.84 Lipid profile of Tenon’s capsule in glaucoma patients
A. Bron, L. Bretillon, S. Grégoire, N.i acar, B. Bardet, C. Creuzot-Garcher (France)
P3.85 Needle revision of failed filtering blebs with high-dose mitomycin-C
S. Jamonsuwan (Thailand)
P3.86 Benzalkonium chloride induces ocular surface inflammation via the chemokine CX3CL1/
fractalkine
A. Denoyer , E. Brasnu, L. Riancho , F. Baudouin, W. Rostene, C. Baudouin (France)
P3.87 Conjunctival complications related to Ahmed glaucoma valve
N. Geffen, M. Smith, A. Anrako, Y. M Buys, T. Alasbali, R. Rachmiel, G.E. Trope
(Canada)
P3.88 The influence of ocular surface diseases in the management of glaucoma
A. Labbé, C. Van Went, E. Brasnu, P. Hamard, C. Baudouin (France)
P3.89 Frequency of eyelash ptosis in glaucoma patients using prostaglandin analogs
S. Ugurlu, R. Avsar, I. Cakir Mermut, M. Cakmakliogullari (Turkey)
P3.90 An evaluation of the usefulness of a uniocular trial of topical glaucoma medication when
initiating topical glaucoma monotherapy
S. Uppal, A. Lakshmanan, A. Abedin, E. Henry, A. Rotchford, A. King (United Kingdom)
P3.91 Can topic prostaglandins analogues induce macular thickness changing in glaucomatous
patients after cataract surgery?
V. Belloli, M. Savastano (Italy)
P3.92 A Gold Shunt Implant (Solx, Inc, Waltham, Massachusetts) absorbed by the anterior face of
the iris pigment
F. Ferentini, A. Porta (Italy)
P3.93 An unexpected side effect of brimonidine use
H. Ozal, T. Tuna, M. Unal, F. Ozturk (Turkey)
P3.94 Transscleral cyclophotocoagulation (TSCPC) in glaucomatous eyes with preserved good
visual acuitY. Own experience
A. Zaleska-Zmijewska, D. Zawadzka, J. Szaflik, J. Izdebska (Poland)
P3.95 Side effects from Cidofovir ™ intravitreal injection in the cases with absolute painful
glaucoma
A. Malayan (Armenia)
P3.96 Complicated YAG laser iridotomy
Z. Frysak, K. Maresova, P. Mlcak, M. Vidlarova (Czech Republic)
P3.97 Prognosis factors of success after deep sclerectomy using ultrasound biomicroscopy
L. Cabrejas, G. Rebolleda, F.J. Muñoz-negrete (Spain)
P3.98 Implants in non penetrating deep sclerectomy: clinical and morphological differences using
ultrasound biomicroscopy
L. Cabrejas, G. Rebolleda, F.J. Muñoz-negrete (Spain)
P3.99 Are there filtering blebs after canaloplasty?
T. Klink, E. Panidou, B. Kanzow-Terai, J. Klink, G. Schlunck, F. Grehn (Germany)
P3.100 Clinical and morphological differences between isolated deep sclerectomy and
combined phaco-deep sclerectomy using ultrasound biomicroscopy
L. Cabrejas, F.J. Muñoz-negrete, G. Rebolleda (Spain)
P3.101 Trypan blue staining for detection and removal of inner wall of Schlemm's canal in
viscocanalostomy
B. Koucheki (Iran)
P3.102 Deep sclerectomy: medium term comparison between three implants
M. Perez-Lopez, P. Casas-Llera, F.J. Muñoz-negrete, G. Rebolleda Fernández,
C. Cabarga del nozal (Spain)
P3.103 Minicanalostomy in POAG
F. Wagdy (Egypt)
P3.104 Anterior segment optical coherence tomography imaging of the filtration site after deep
sclerectomy
Z. Varga, N. Mavrakanas, T. Shaarawy (Switzerland)
P3.105 Outcomes of non-penetrating deep sclerectomy without scleral implant. 3 years follow-up
A. Espino-Garcia , E. Arranz-Marquez , M.A. Teus (Spain)
P3.106 Phacoviscocanalostomy: is the use of a viscoelastic really necessary?
K. Hassan, M. Awadallah (Saudi Arabia, Egypt)
P3.107 Long-term results (10 years) of deep sclerectomy with use of antimetabolites in open angle
glaucoma
Y. Lachkar, E. Butchukuri, F. Valtot, J. Kopel (France)
P3.108 Canaloplasty: a 2-year experience
P. Brusini, C. Tosoni (Italy)
P3.109 Comparison of Esnoper® implant with and without suprachoroidal placement in non
penetrating deep sclerectomy
Y.W. Eduardo Sánchez, M.D. Lago Llinas, M. Montero Rodríguez, E. Gutiérrez díaz
(Spain)
P3.110 Deep sclerectomy with non absorbable implant Esnoper (V-2000) versus T-Flux.
Comparative studY. Report at one year
J.I. Belda Sanchis, J. Placeres daban, M.C. Calatayud, J. Ruiz Colecha (Spain)
P3.111 Excimer laser-assisted nonpenetrating deep sclerectomy
A. Maldonado-Bas, A. Maldonado Junyent, A. Maldonado Junyent (Argentina)
P3.112 Non penetrating deep sclerectomy and trabeculotomy for glaucoma
A. Maldonado Junyent, A. Maldonado-Bas, A. Maldonado Junyent (Argentina)
P3.113 Third flap dissection in viscocanalostomy
K. Hassan (Saudi Arabia)
P3.114 Surgical treatment and patient perceived benefit of coexistant advanced or end-stage
glaucoma with controlled intraocular pressure and visually significant cataract
A. Liaska, D. Papakonstantinou, P. Theodosiadis, I. Vergados (Greece)
P3.115 Comparison of postoperative wavefront aberrations due to differences in the incisions in
simultaneous cataract surgery combined with trabeculectomy
T. Noro, T. Nakano, S. Ogawa, M. Tatemichi, H. Tsuneoka (Japan)
P3.116 One-site versus two-site fornix based phacotrabeculectomy in patients with
pseudoexpholiativum glaucoma
Z. Mandic, M. Zoric Geber, I. Petric Vickovic, K. Novak Laus (Croatia)
P3.117 Postoperative refractive outcomes in phacotrabeculectomy in comparison to
phacoemulsification
I. Orignac, V. Paire, B. Vabres, M. Weber (France)
P3.118 Washout of pseudoexfoliation material in trabecular meshwork: a new surgical approach
for PEX glaucoma
Y. Bifrare , A. Mermoud , V.T. Tran (Switzerland)
P3.119 The results of phacotrabeculectomy
P. Mlcak, M. Karhanova, Z. Frysak (Czech Republic)
P3.120 Tactics of glaucoma treatment in patients with clear lens swelling complication
N. Yusifova (Azerbaijan)
P3.121 Successive bilateral phacotrabeculectomy in uncontrolled pseudoexfoliation glaucoma: a
case report
K. Maresova, M. Karhanova, Z. Frysak, J. Rehak (Czech Republic)
P3.121 bis The results of combined trabeculectomy and cataract extraction with IOL-implantation
G. Oganova (Armenia)
P3.122 Surgical results of Ahmed valve implantation with intraoperative bevacizumab injection in
patients with refractory neovascular glaucoma
J.Y. Yang, J.H. Kim, N.R. Kim, S. Hong, G.J. Seong, C.Y. Kim, K.T. Ma (Korea)
P3.123 Improved MR imaging for aqueous fluid drainage after glaucoma drainage implant surgery
without contrast agent
T. Sone, K. Tanitame, Y. Kiyama, H. Fukuda, P. Arintawati, Y. Kiuchi (Japan)
P3.124 5 years of experience in application of “Hemashield” drainage device in patients with
different types of glaucoma
N. Palarie, T. Pasenco (Moldova)
P3.125 Ex-Press® mini glaucoma shunt versus standard trabeculectomy
I. Sampaio, M.A. Costa, M. Macedo, M.J. Menéres, C. Aguiar (Portugal)
P3.126 Microdevice for treatment of refractory glaucoma intrascleral microimplant
A. Maldonado Junyent, A. Maldonado-Bas, A. Maldonado Junyent (Argentina)
P3.127 Intracameral ligature of glaucoma drainage devices to treat post-operative hypotony
S. Biswas, A. Gupta, V. Sung (United Kingdom)
P3.128 Combined 23 gauge pars plana vitrectomy and Ahmed valve implantation to treat
aqueous misdirection syndrome following cataract surgery
C. Pallas, G. Clare, H. Pallas, B. Corcostegui (Spain, United Kingdom)
P3.129 Ahmed valve implantation in patient with previous penetrating keratoplasty and anterior
chamber intraocular lens
H. Pallas, C. Pallas, B. Corcostegui, J.L. Guell (Spain)
P3.130 Scheimpflug imaging system used to study the position of the tube of drainage devices
L. Zarratea Herreros, E. Gutierrez diaz, M. Montero Rodriguez, M.D. Lago Llinas
(Spain)
P3.131 Our first experience with ex-press mini glaucoma shunt implantation in Eye Clinic
"Svjetlost", Zagreb, Croatia
M. Gavric, N. Gabric, K. Matkovic, M. Lukic (Croatia)
P3.132 Inferior-nasal Ahmed valve implant as a final solution to superior quadrant failure
M. Montero Rodriguez, L. Zarratea Herreros, F.J. Guijarro Oria, E. Gutierrez diaz
(Spain)
P3.133 Surgical treatment of secondary post burn refractory glaucoma
S. Iakymenko, P. Kostenko (Ukraine)
P3.134 Triple surgery combining pars plana vitrectomy, Ahmed valve implantation and Boston
type 1 keratoprosthesis to treat complicated congenital glaucoma
C. Pallas, G. Clare, H. Pallas, J.L. Guell (Spain, United Kingdom)
P3.135 Ex-press assisted aqueous sclero-suprachoroidal outflow pathway
M.J. Gonzalez Rodriguez, A.J. Gómez Carnero, R. Socias Segura (Spain)
P3.136 Analysis of referral pattern and outcome of YAG laser peripheral iridotomy
N. Mathew, A. Zaheer, G. Ghosh (United Kingdom)
P3.137 Clear lens phacoemulsification and intraocular lens implant as a treatment modality in
angle closure eyes following YAG laser peripheral iridotomy
S. Mukherji, W. Nolan, M. Nessim (United Kingdom)
P3.138 Phacoemulsyfication with PIOL implantation and anterior iris synechiae release in primary
angle closure glaucoma treatment
R. Wasilewicz, J. Kociecki, P. Wasilewicz (Poland)
P3.139 Lysis of posterior synechiae in acute uveitis using a combination of intraocular tissue
plasminogen activator and posterior sub-Tenon’s triamcinolone acetonide
A. Jayaprakash Patil, L. Lerner, M.C. Kenney, D. Minckler (United Kingdom, USA)
P3.140 Treatment of plateau-like iris secondary to ciliary body cysts
M. Valero Figueroa, C. Tapia, M. Moussalli, A. Burchakchi, N. Montañez, M. Moussalli
(Argentina)
P3.141 Results of YAG laser peripheral iridotomy in primary angle closure suspects
A.A. Dahawy, D.K. Nair, A. Abdel azeem, N. Rahman (United Arab Emirates)
P3.142 Campylobacter jejuni gastroentritis presenting as bilateral angle closure glaucoma
S. Mukherji, S. Ramanathan, S. Tarin (United Kingdom)
P3.143 Effects of peripheral laser iridotomy in patients with closed angle
S. Hyung, D. Choi, C.S. Kim, J. Moon, G.J. Seong, J.H. Lee, K.W. Lee (Korea)
P3.144 Intravitreous ranibezumab as adjunctive treatment for trabeculectomy in neovascular
glaucoma
N. Kitnarong, C. Sriyakul, S. Chinwattanakul (Thailand)
P3.145 Secondary glaucoma complication after stereotactic radiosurgery for uveal melanoma
A. Furdova, M. Sramka, Z. Svetlosakova (Slovak Republic)
P3.146 Effect of diode laser trans-scleral cyclophotocoagulation for secondary glaucoma
persisting after silicone oil removal
K. Novak Laus, Z. Mandic, I. Krolo, B. Andrijevic derk, M. Zoric Geber, Z. Vatavuk
(Croatia)
P3.147 Three cases of lens-induced secondary glaucoma with combined mechanism which
developed several years after cataract surgery
K. Tada, M. Ueno, K. Mori, Y. Ikeda, K. Imai, S. Kinoshita (Japan)
P3.148 Secondary glaucoma due to trabeculitis in herpes simplex virus (HSV) keratitis
I. Carrillo arroyo, P. Gómez Pérez, E. Gutiérrez díaz, M. Montero Rodríguez,
E. Mencía Gutiérrez (Spain)
P3.149 Bevacizumab using to hemorrhagic complications prevention in neovascular glaucoma
surgery (case report)
G. Vashkevich, I. Malinouskaya, T. Imshenetskaya (Belarus)
P3.150 Diabetic retinopathy in a patient with Wolfram syndrome
T. Tuna, M. Unal , G.Koklu, A.G. Kocak altintas (Turkey)
P3.151 Seventy year delayed onset of phacolytic glaucoma following posterior lens dislocation
P. Gohier, S. Leruez, A. Lecq, G. Jallet, D. Miléa (France)
P3.152 A case report of cholesterosis bulbi concurrent with secondary glaucoma treated by partial
vitrectomy and intravitreal injection of bevacizumab
H. Lee, H.Y. Lee, Y. Kim, J. Park (Korea)
P3.153 Effect of the fixed combination timolole maleate 0.5 % and brimonidine tartarate 0.2 % eye
drops on intraocular pressure and clinical activity score in patients with secondary
glaucoma to thyroid associated orbitopathy
T. Simsek, G. Acaroglu, B. Çankaya, G. Ertugrul (Turkey)
P3.154 Ahmed glaucoma valve implantation as a treatment for secondary glaucoma due to
keratoprosthesis surgery
G. Sukiasyan, L. Voskanyan, A. Hovakimyan (Armenia)
P3.155 Glaucoma associated with sickle cell trait hyphema and non invasive treatment:
transcorneal oxygen therapy
I. Figueras, A. Carceller, A. Dou, L. Loras (Spain)
P3.156 Usage of semiconductor laser as the starting point of neovascular glaucoma treatment
I. Buniatyan (Armenia)
P3.157 Neovascular glaucoma treated by cyclocryoanemisatio
S. Sreckovic, T. Sarenac, N. Petrovic, M. Simeunovic, I. Stojanovic (Serbia)
P3.158 Repeated primary spontaneous prolapse of the posterior-chamber lense with the
secondary glaucoma
S. Avramovic , M. Bozic (Serbia)
P3.159 Glaucoma features and treatment in patients with lenticular myopia, ectopia lentis,
glaucoma, spherophakia and short stature (LEGSS) syndrome
J. Morales, N. Al Tassan, R. Al Mahrouqi, L. Al Sharif, A. Al Rahji (Saudi Arabia)
P3.160 Intermediate results in drainage devices for pediatric glaucoma
T. Colás Tomás, E. Gutiérrez díaz, P. Tejada Palacios, A. Barceló Mendiguchía,
E. Mencía Gutiérrez (Spain)
P3.161 Endophthalmitis associated with Ahmed glaucoma valve implant in pediatric patients
M.B. Pastor nieto, J. Zarallo Gallardo, A. Grabowska, J. Peralta Calvo,
J. Abelairas Gómez (Spain)
P3.162 Neovascular glaucoma in neurofibromatosis type 1 (NF1)
S. Al Freihi , D.P. Edward , M. Abu amo , S. Nowilaty , J. Morales (Saudi Arabia, USA)
POSTER SESSION 4
INTRAOCULAR PRESSURE – BIOMECHANICS – GENETICS – NEUROPROTECTION – BLOOD FLOW
P4.1 Heritability of glaucoma traits. A review of twin and family studies
D. Mackey, P. Sanfilippo, A. Hewitt, C. Hammond (Australia, United Kingdom)
P4.2 Toxicological evaluation of preservative-containing and preservative-free topical prostaglandin analogs on a 3D-reconstituted corneal epithelium system
H. Liang, F. Brignole-Baudouin, A. Pauly, L. Riancho, A. Labbé, C. Baudouin (France)
P4.3 CYP1B1 gene analysis in a Turkish developmental glaucoma family with variable
expression
Ö.G. Köz, H. Ilgın-Ruhi, P. Bayrak-Toydemir, A. Yarangümeli, G. Kural (Turkey, USA)
P4.4 ASK1 deficiency attenuates neural cell death in a mouse model of normal tension glaucoma
T. Harada, C. Harada (Japan)
P4.5 Association of TP53 codon 72 polymorphism with primary angle closure glaucoma
in Brazilian patients
M.J. Lopes da Silva, J. Silva Paula, N. Saloum deghaide, M. Abelin Vargas, E. Da Cruz Castelli, E. Donadi, M.D.L. Veronese Rodrigues (Brazil)
P4.6 Retinal ganglion cell protection via topical and systemic alpha tocopherol administration in
optic nerve crush model of rat
Z. Aktas, C. Ozmen, P. Uyar Gocun, Z. Degim, Y. Ozkan, M. Onol, N. Celebi, B. Hasanreisoglu (Turkey)
P4.7 Systemic citicoline (cytidine-5'-phosphocholine) is able to improve visual function in primary
open-angle glaucoma
M. Virno, P. Brusini, G. Garofalo, C. Tosoni, J. Pecori Giraldi (Italy)
P4.8 Novel intellectual therapeutic laser system and its application
Z. Alyabyeva, A. Larichev, E. Kantarzhi, N.a Iroshnikov, A. Goncharov (Russia)
P4.9 Dysregulation of pheripheral circulation in normal tension glaucoma patients
G.J. Seong, S. Hong, S. Hyung, B.J. Cho, C.Y. Kim (Korea)
P4.10 Hemodynamic response of the ophthalmic artery to cold pressor test on young subjects
L. Abegão Pinto, S. Raposo, I. Rocha, C. Marques-neves (Portugal)
P4.11 Agreement among three examiners of color Doppler imaging retrobulbar blood flow velocity
measurements
P. Founti, D.Papadopoulou, P. Emmanouilidis, B. Siesky, V. Kilintzis, E. Anastasopoulos, A. Salonikiou, T. Pappas, A. Harris, F. Topouzis (Greece, USA)
P4.12 The expression of prostanoid receptor subtype, eNOS by prostaglandin analogue in human
umbilical vein endothelial cells (HUVEC) and cord smooth muscle cells (cSMC)
S.J. Ha (Korea)
P4.13 Peripheral vascular compliance in open angle glaucoma patients as compared to
non-glaucoma patients
A.How, R. Kawasaki, A. Jenkins, J. Crowston (Australia)
P4.14 The necessity of eye hemodynamic study for choice of topical drugs in treatment of open-
angle glaucoma
N. Zavgorodnyaya, N. Lutsenko (Ukraine)
P4.15 Estimation of visual field progression rate in normal-tension glaucoma with unstable ocular
perfusion pressure
K.R. Sung, J.W. Cho, Y. Lee, M.S. Kook (Korea)
P4.16 Intraocular pressure changes after endonasal endoscopic orbital decompression in patients
with thyroid-associated ophthalmopathy (TAO)
M. Karhanova, I. Skodova, Z. Frysak, K. Maresova, P. Mlcak, Z. Frysak Jr., J. Rehak (Czech Republic)
P4.17 Biomechanical properties of the cornea in ocular hypertension
C. Altan, B. Satana, B. Demirel, E. Azman, A.T. Yazici, A. Demirok, O.F. Yilmaz (Turkey)
P4.18 The effects of travoprost on the biomechanical properties of the cornea
C. Altan, B. Satana, G. Varan, B. Demirel, E. Bozkurt, A. Demirok, O.F. Yilmaz (Turkey)
P4.19 Effect of acute increases of intraocular pressure on the intrastromal corneal pressure. An
animal study
G. Bolivar, M.A. Castejon, M. Teus (Spain)
P4.20 The impact of glaucoma stage on the ocular biomechanics
M. Haustein, S. Hadjisraftis, L.E. Pillunat, E. Spoerl (Germany)
P4.21 Continuous measurement of the intraocular pressure by a contact lens integrating a sensor
S. De Smedt, A. Mermoud (Switzerland)
P4.22 Nurse led intraocular pressure measurements in Moorfields St George's Hospital: an audit
D. Gkotsi, A. Spiteri (United Kingdom)
P4.23 Plasma and aqueous humor levels of ghrelin in open angle glaucoma patients
A. Dastiridou, A. Katsanos, P. Georgoulias, P. Cholevas, M. Kotoula, E. Tsironi (Greece)
P4.24 Prognosis of intraocular pressure elevation after intravitreal triamcinolone acetonide
injection
B. Jelliti, R. Kahloun, W. Ammar, S. Mabarek, I. Kacem, R. Messaoud, S. Attia, S. Zaouali, M.Khairallah (Tunisia)
P4.25 The effects of SCUBA diving activities on intraocular pressure, optic nerve, and visual field
J.D. Kwon, H.Y. Song, J.H. Jin (Korea)
P4.26 Central corneal thickness and It’s correlation with axial length in pediatric high hyperopia
B. Satana, C. Altan, B. Gokyigit, S. Akar, I. Parente, A. Demirok, O.F. Yilmaz (Turkey)
P4.27 Investigation into the relationship between anterior segment anatomy, corneal biomechanics
and refractive error in 10-12 year old school boys
A. Shah, S. Low, P.S. Lee, E. White, P. Foster, D. Garway-Heath, K. Barton (United Kingdom)
P4.28 Correlation of aqueous humor levels of MMP-2 and TIMPs 1-4 with clinical findings
in patients with pseudoexfoliation syndrome/glaucoma and primary open-angle glaucoma
J. Djordjevi-Jocic, G. Zlatanovic, P. Jovanovic, D. Veselinivic, V. Djordjevic, M. Zenkel, U. Schlötzer-Schrehardt (Serbia, Germany)
P4.29 Sleep apnoea syndrome and structural suspicion of glaucoma
M. Castany aregall, A. Carceller, A. Dou, A. Anton, J. Catala, N. Grau, N. Moreno, M. Castilla (Spain)